Advertisement

European Journal of Pediatrics

, Volume 177, Issue 6, pp 867–870 | Cite as

The viability of probiotics in water, breast milk, and infant formula

  • Claire Watkins
  • Kiera Murphy
  • Eugene M. Dempsey
  • Brendan P. Murphy
  • Paul W. O’Toole
  • R. Paul Ross
  • Catherine Stanton
  • C. Anthony Ryan
Original Article

Abstract

The aim of this study was to determine bacteriological stability of a probiotic mixture dispersed in various diluents. The commercially available probiotic (Infloran®), containing Bifidobacterium bifidum (109 CFU/250 mg tablet) and Lactobacillus acidophilus (109 CFU/250 mg tablet), was dispersed within expressed breast milk, sterile water, and infant formula and examined at temperatures of 4 and 21 °C. When stored at 4 °C, significant decreases (P < 0.05) in the level of L. acidophilus and B. bifidum were observed in expressed breast milk and sterile water after a 6-h period. However, when stored in infant formula, both strains remained stable over a 12-h period. When stored at 21 °C, a significant decrease (P < 0.05) was observed in the level of L. acidophilus in sterile water, expressed breast milk and infant formula throughout a 12-h period. However, no significant decrease was observed overtime in B. bifidum in all three diluents at this temperature.

Conclusion: Our findings suggest that, when stored at 4 °C, this probiotic product can remain at a stable condition for 6 h in sterile water and infant formula; however, the viability of the probiotic decreases significantly after this period of time. Administration of this probiotic in sterile water can be an acceptable alternative to dispersion and administration in expressed breast milk.

What is Known:

Administration of probiotics containing lactobacilli and bifidobacteria has become more widespread in neonatology, mainly as prophylaxis for the prevention of necrotising entercolitis in preterm infants.

Probiotic reconstitution, from its powder base, is not standardized and various diluents, including sterile water, breast milk, and infant formula, have been used.

What is New:

When stored at 4 °C, a probiotic containing lactobacilli and bifidobacteria remains at a stable microbological condition for up to 6 h in sterile water.

Administration of this probiotic dispersed in sterile water, followed by an EBM feed, can be an acceptable alternative to dispersion and administration in EBM.

Keywords

Probiotics Expressed breast milk Water Preterm Newborns 

Abbreviations

EBM

Expressed breast milk

LBS

Lactobacillus selection

MRS

de Mann, Rogosa and Sharpe

NEC

Necrotising enter colitis

Notes

Acknowledgements

The authors acknowledge the assistance of Carol-Anne O′ Shea and Maura Cahill from the Cork University Maternity Hospital (CUMH) for their help in providing the probiotic and for demonstrating probiotic administration in the NICU.

Authors’ contributions

Prof Tony Ryan, Eugene Dempsey, and Prof Paul W O’ Toole were responsible for substantial contributions to the conception and design of the work.

Claire Watkins acquired the data that was analyzed; Claire Watkins and Kiera Murphy analyzed and assisted with the interpretation of data of the work with Prof Paul Ross, Prof Catherine Stanton, and Prof Tony Ryan.

Drafting of the work and revising it critically for important intellectual content were carried out by Claire Watkins, Prof Tony Ryan, and Brendan P Murphy.

Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved by all authors.

Funding

The authors are supported, in part, by the Science Foundation Ireland, through The APC Microbiome Institute (APC), and INFANTMET (Project (Ref No 10FDairy), funded by the Food Institutional Research Measure (FIRM) of the Department of Agriculture, Food and the Marine.

Compliance with ethical standards

The research does not involve human or animals. This study did not require informed consent. Ethical approval for the study was granted from Clinical Research Ethics Committee of the Cork Teaching Hospitals. (ECM4(M)01/09/15& (EMC)(dddddddd)12/04/16.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Collado MC, Sanz Y (2006) Method for direct selection of potentially probiotic Bifidobacterium strains from human feces based on their acid-adaptation ability. J Microbiol Methods 66(3):560–563CrossRefPubMedGoogle Scholar
  2. 2.
    Corcoran BM, Stanton C, Fitzgerald GF, Ross RP (2005) Survival of probiotic lactobacilli in acidic environments is enhanced in the presence of metabolizable sugars. Appl Environ Microbiol 71(6):3060–3067CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Deshpande G, Rao S, Patole S, Bulsara M (2010) Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 125:921–930CrossRefPubMedGoogle Scholar
  4. 4.
    Deshpande G, Rao SC, Keil AD, Patole S (2011) Evidence-based guidelines for use of probiotics in preterm neonates. BMC Med 9:92CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Deshpande G, Rao SC, Patole S (2015) Probiotics in neonatal intensive care—back to the future. Aust N Z J Obstet Gynaecol 55(3):210–217CrossRefPubMedGoogle Scholar
  6. 6.
    Hoyert DL, Jiaquan X Deaths: preliminary data for 2011—selected causes. Natl Vital Stat Rep 6:40–42Google Scholar
  7. 7.
    Larsen N, Vogensen FK, Gøbel R, Michaelsen KF, Al-Soud WA, Sørensen SJ, Hansen LH, Jakobsen M (2011) Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07. FEMS Microbiol Ecol 75(3):482–496CrossRefPubMedGoogle Scholar
  8. 8.
    Macfarlane S, Macfarlane GT (2003) Regulation of short-chain fatty acid production. Proc Nutr Soc 62:67–72CrossRefPubMedGoogle Scholar
  9. 9.
    Shigwedha N and Jia L (2013) Bifidobacterium in human GI tract: screening, isolation, survival and growth kinetics in simulated gastrointestinal conditions. In Lactic Acid Bacteria-R & D for Food, Health and Livestock Purposes. InTech. doi: 10.5772/50457Google Scholar
  10. 10.
    Tarnow-Mordi WO, Wilkinson D, Trivedi A, Brok J (2010) Probiotics reduce all-cause mortality and necrotizing enterocolitis: it is time to change practice. Pediatrics 125:1068–1070CrossRefPubMedGoogle Scholar
  11. 11.
    Wang Y, Hoenig JD, Malin KJ, Malin KJ, Qamar S, Petrof OE, Sun J, Antonopoulos AD, Chang EB, Claud EC (2009) 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J 3:944–954CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Claire Watkins
    • 1
    • 2
  • Kiera Murphy
    • 1
    • 2
  • Eugene M. Dempsey
    • 3
    • 4
  • Brendan P. Murphy
    • 3
    • 4
  • Paul W. O’Toole
    • 2
    • 5
  • R. Paul Ross
    • 1
    • 5
  • Catherine Stanton
    • 1
    • 5
  • C. Anthony Ryan
    • 3
    • 4
  1. 1.Teagasc Food Research ProgrammeCo. CorkIreland
  2. 2.Department of MicrobiologyUniversity College CorkCorkIreland
  3. 3.Department of Paediatric and Child HealthNeonatology Department, Cork University Maternity HospitalCorkIreland
  4. 4.Department of NeonatologyCork University Maternity HospitalCorkIreland
  5. 5.APC Microbiome Ireland , Biosciences InstituteCorkIreland

Personalised recommendations